Receptor testing of the affinity and potency of compounds is a critical component of psychedelic research.
This company is approaching psychedelic mushroom research literally from the ground up.
Novel chemical variants of ibogaine may offer therapeutic benefits without severe side effects.
This influential study advances the understanding of magic mushroom physiology and helps answer several fundamental questions.
This is the first time since the 1970s that a Canadian company has legally cultivated and harvested psychedelic mushrooms.
From cow dung to coffee grounds. this species grows well on a variety of substrates.
Connectome-Specific Harmonic Waves: A new way of looking at the brain sheds light on the biological correlates of consciousness.
The first trial will determine the sublingual dose equivalent to 25 mg psilocybin administered orally.
Cultivating P. cubensis: Light and Tryptamine Are Key for Controlling Psilocybin and Psilocin Levels
No light and increasing tryptamine in the growing medium leads to more psilocin but less psilocybin in the mushrooms.
Research is indicating that a less efficient metabolic pathway plays a role in DMT’s psychoactivity.